Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

NCT07321652 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

466

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Leukemia

Interventions

DRUG: Zanubrutinib
DRUG: Sonrotoclax
PROCEDURE: Computed Tomography
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Biospecimen Collection
OTHER: Survey Administration

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]